For the quarter ending 2026-03-31, CTEV has $4,839,299K in assets. $5,073,713K in debts. $21,327K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 21,327 | 16,814 | 39,152 | 56,390 |
| Restricted cash | 13,401 | 11,527 | 11,493 | 10,898 |
| Trade accounts receivable, net | 140,917 | 127,615 | 126,992 | 123,579 |
| Prepaid expenses | 35,349 | 31,992 | 21,768 | 26,241 |
| Prepaid taxes | 4,101 | 11,526 | 33,019 | 0 |
| Unbilled independent dispute resolution fees, net | 13,304 | 10,563 | 15,362 | 18,993 |
| Other current assets, net | 13,868 | 14,330 | 9,672 | 11,037 |
| Total current assets | 242,267 | 224,367 | 257,458 | 247,138 |
| Property and equipment, net | 343,599 | 326,326 | 316,964 | 308,358 |
| Operating lease right-of-use assets | 13,549 | 13,966 | 13,326 | 15,056 |
| Goodwill | 2,405,853 | 2,405,853 | 2,403,140 | 2,403,140 |
| Other intangibles, net | 1,798,696 | 1,884,604 | 1,968,411 | 2,054,381 |
| Other assets, net | 35,335 | 33,342 | 31,002 | 43,907 |
| Total assets | 4,839,299 | 4,888,458 | 4,990,301 | 5,071,980 |
| Accrued taxes | - | - | - | 10,909 |
| Accounts payable | 59,176 | 60,463 | 38,926 | 43,431 |
| Accrued interest | 52,277 | 100,009 | 54,255 | 100,254 |
| Operating lease obligation, short-term | 4,907 | 4,705 | 4,826 | 4,466 |
| Current portion of long-term debt | 14,690 | 14,690 | 14,690 | 14,690 |
| Accrued compensation | 19,672 | 45,238 | 53,199 | 37,982 |
| Other accrued expenses | 38,842 | 36,253 | 47,421 | 41,410 |
| Total current liabilities | 189,564 | 261,358 | 213,317 | 253,142 |
| Private placement warrants and unvested founder shares | - | - | - | 0 |
| Long-term debt | 4,574,253 | 4,560,440 | 4,546,671 | 4,533,078 |
| Other liabilities | - | 0 | 0 | 2,584 |
| 2025 revolving credit facility | 125,000 | 20,000 | 70,000 | 80,000 |
| Operating lease obligation, long-term | 15,060 | 16,236 | 16,239 | 17,207 |
| Deferred income taxes | 169,836 | 197,599 | 245,909 | 225,877 |
| Total liabilities | 5,073,713 | 5,055,633 | 5,092,136 | 5,111,888 |
| Common stock, 0.0001 par value 1,500,000,000 shares authorized 17,743,149 and 17,295,582 issued 17,000,290 and 16,552,723 shares outstanding as of march 31, 2026 and december 31, 2025, respectively | 2 | 2 | 2 | 2 |
| Additional paid-in capital | 2,402,923 | 2,398,423 | 2,390,886 | 2,383,854 |
| Accumulated deficit | -2,502,980 | -2,429,420 | -2,348,850 | -2,279,097 |
| Accumulated other comprehensive loss | -2,351 | -4,172 | -5,140 | -5,934 |
| Treasury stock - 742,859 shares as of march 31, 2026 and december 31, 2025 | 138,733 | 138,733 | 138,733 | 138,733 |
| Total shareholders (deficit)/equity attributable to claritev corporation | -241,139 | -173,900 | -101,835 | -39,908 |
| Non-controlling interests | 6,725 | 6,725 | - | - |
| Total shareholders' deficit | -234,414 | -167,175 | - | - |
| Total liabilities and shareholders deficit | 4,839,299 | 4,888,458 | 4,990,301 | 5,071,980 |